G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Market Cap	2.42B -23.6%
Revenue (ttm)	311.78M +37.9%
Net Income	143.10M +60.4%
EPS	2.24 +60.1%
Shares Out	63.72M
PE Ratio	16.95
Forward PE	n/a
Dividend	0.70 (1.84%)
Ex-Dividend Date	Jul 29, 2025

Volume	35,139
Average Volume	44,267
Open	38.00
Previous Close	38.00
Day's Range	37.90 - 38.60
52-Week Range	36.65 - 56.60
Beta	-0.86
RSI	26.60
Earnings Date	Mar 19, 2026

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products in Taiwan. It offers Hepanamin capsules; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 39
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2024, G&E Herbal Biotechnology's revenue was 249.03 million, an increase of 37.25% compared to the previous year's 181.44 million. Earnings were 102.06 million, an increase of 40.97%.